Hope for Huntington’s Disease: New Gene Therapy Shows Promise
Last month, there was exciting news for people with Huntington’s disease. A new gene therapy called AMT-130, made by uniQure, […]
Last month, there was exciting news for people with Huntington’s disease. A new gene therapy called AMT-130, made by uniQure, […]
Bristol Myers Squibb (BMS) has bought Orbital Therapeutics, a US biotech company, for $1.5 billion. This deal is mainly about
Vertex Pharmaceuticals, known for its groundbreaking CRISPR-based therapy for sickle cell disease, is now focusing on Type 1 diabetes. Their
Immunology is a powerful tool in the world of medicine, helping to create new treatments for various conditions, from cancer
A pharmaceutical manufacturing site in Indiana, now owned by Novo Nordisk after their purchase of Catalent in 2024, has been
Enterome, a biopharmaceutical company, has been given a special status called ‘fast track designation’ by the US Food and Drug
The National Institute for Health and Care Research (NIHR) has big plans to improve healthcare. They’re investing £157 million over
The field of psychedelics-based drug development has been promising for mental health treatments, but it hasn’t yet delivered significant breakthroughs.
Hi there, I’m Abigail Beaney. I’m the editor of Clinical Trials Arena, a place where we talk about all things
The European Commission has shared its plans to boost the use of artificial intelligence (AI) in science and healthcare across